(Date:12/11/2009)... 11, 2009 -- Esco announces the opening of a NEW 2nd ... a technical service, training and logistics center to support Esco,s growth ... Product Introductions (NPI) for temperature-controlled laboratory equipment. , ... ... of a NEW 2nd North American facility in Marietta, OH. The ...
(Date:12/10/2009)... 10 With the economy and markets exhibiting ... largest, fastest-growing small cap equity research provider, will seek ... opportunities within the micro cap market at the firm,s ... 11, 2010 at the Grand Hyatt Hotel in New ... overlooked and undervalued by much of Wall Street, but ...
(Date:12/10/2009)... CORALVILLE, Iowa, Dec. 10 Vivakor, ... that it has entered into an exclusive, ... specialist, Regeneca International, Inc. ( www.regeneca.com ). ... distribution rights to a new cutting-edge nutraceutical ... the development of future formulations by Vivakor ...
(Date:12/10/2009)... Create Optimized Antibodies Produces First Candidates Which ... MISSISSAUGA, ON, Dec. 10 /PRNewswire-FirstCall/ - YM ... the first results of a collaborative program ... Council of Canada,s Biotechnology Research Institute ... is designed to generate novel antibodies that ...
Breaking Biology Technology:Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Company's First Annual 2010 Micro Cap Conference 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5... (Nasdaq: ALGN ) today announced that it ... Labour and Welfare (MHLW). The Company,may now begin ... has trained approximately 660 Invisalign orthodontists since launching the,product ... "This regulatory approval in Japan is an ...
... Prosolia, Inc. introduces a new,advanced Omni Spray Ion Source model ... 2-D Ion Source has an automated,surface platform which enables rapid ... 76 mm by 114 mm, which is the size of ... The Omni Spray 2-D Ion Source achieves a ...
... COUNTY, Calif., Dec. 8 Beckman Coulter,Inc. (NYSE: ... simplify, automate, and innovate complex biomedical tests, will host its,Annual ... December 16,2008, from 9:00 a.m. to 12:00 p.m. (ET). , ... ) , The live ...
Other Biology Technology:Align Technology Receives Expanded Regulatory Approval in Japan 2Prosolia to Introduce Omni Spray(R) Ion Source in 2-D Format 2... team of researchers, including Kent State University professor Dr. ... the seasonal mass migration of Mormon crickets in western ... for protein and salt, and a fear of cannibalism, ... North America. , Throughout their seasonal migration, millions ...
... boosting anti-cancer drugs' effectiveness and lowering their toxicity by ... drugs. This extra weight makes the drugs penetrate and ... fall short of achieving their full impact because the ... rapidly, said the scientists from Duke University Medical Center ...
... future in which each patient's tumor will act like ... cancer to obtain the best outcome. , Currently, ... receive extra therapy after surgery - or whether some ... not even require surgery. Most patients with colorectal cancer ...
Other Biology News:Weighting cancer drugs to make them hit tumors harder 2Weighting cancer drugs to make them hit tumors harder 3Weighting cancer drugs to make them hit tumors harder 4Markers of gene, protein, or micro-RNA activity predict outcome in prostate and colorectal cancers 2Markers of gene, protein, or micro-RNA activity predict outcome in prostate and colorectal cancers 3Markers of gene, protein, or micro-RNA activity predict outcome in prostate and colorectal cancers 4Markers of gene, protein, or micro-RNA activity predict outcome in prostate and colorectal cancers 5Markers of gene, protein, or micro-RNA activity predict outcome in prostate and colorectal cancers 6Markers of gene, protein, or micro-RNA activity predict outcome in prostate and colorectal cancers 7PEG 8000, Molecular Biology Grade...
Human VASA Biotinylated Affinity Purified PAb...
Recombinant Mouse Matrilin-4, CF Protein Family: Extracellular Matrix Molecules, Chondrogenesis Markers...
An instrument that delivers an accurate and uniform amount of light energy to cells to photoactivate csiRNA products....
Biology Products:Biology NavigationMedical Navigation